Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report
Coronavirus disease 2019 (COVID-19) is currently a major public health problem. The development of pulmonary fibrosis secondary to acute respiratory distress syndrome (ARDS) is one of the expected sequelae. In this case series, we describe five instances of the use of anakinra in late-phase COVID-19...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
SMC MEDIA SRL
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2c88b730844e40fd9fd30026631acb45 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|